NYSEAMERICAN : PLX
Protalix BioTherapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 2.59 USD (Oct 30, 2026, 10:12 AM EDT) · Market cap 208.68M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Protalix BioTherapeutics, Inc. (PLX) reported revenue of 80.62M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 80.62M | 52.74M | 53.40M | 65.49M | 47.64M | 38.35M |
| Cost of Revenue | 43.72M | 45.88M | 36.70M | 39.30M | 48.42M | 16.35M |
| Gross Profit | 36.90M | 6.86M | 16.70M | 26.20M | -785.00K | 22.00M |
| Selling, General & Admin | 12.62M | 11.68M | 12.19M | 14.96M | 11.71M | 12.73M |
| Research & Development | 990.00K | 680.00K | 589.00K | 777.00K | 518.00K | 29.73M |
| Operating Expenses | 13.61M | 12.36M | 12.78M | 15.74M | 12.23M | 42.46M |
| Operating Income | 23.29M | -5.50M | 3.92M | 10.46M | -13.01M | -20.46M |
| Interest Expense | -1.23M | -1.19M | -1.06M | -3.18M | -2.53M | -7.52M |
| Interest & Investment Income | 1.40M | 1.08M | 1.30M | 1.29M | 1.15M | 401.00K |
| EBT Excluding Unusual Items | 23.46M | -5.61M | 4.15M | 8.57M | -14.40M | -27.58M |
| Pretax Income | 23.46M | -5.61M | 4.15M | 8.57M | -14.40M | -27.58M |
| Income Tax Expense | 4.52M | 996.00K | 1.22M | 254.00K | 530.00K | |
| Earnings From Continuing Operations | 18.95M | -6.60M | 2.93M | 8.31M | -14.93M | -27.58M |
| Net Income | 18.95M | -6.60M | 2.93M | 8.31M | -14.93M | -27.58M |
| Net Income to Common | 18.95M | -6.60M | 2.93M | 8.31M | -14.93M | -27.58M |
| Shares Outstanding (Basic) | 79.66M | 78.55M | 72.53M | 67.51M | 48.47M | 44.14M |
| Shares Outstanding (Diluted) | 81.13M | 78.55M | 81.06M | 82.42M | 48.47M | 44.14M |
| EPS (Basic) | 0.24 | -0.08 | 0.04 | 0.12 | -0.31 | -0.62 |
| EPS (Diluted) | 0.24 | -0.08 | 0.04 | 0.09 | -0.31 | -0.62 |
| Free Cash Flow | 7.67M | -13.63M | 7.39M | -2.47M | -25.63M | -11.74M |
| Free Cash Flow Per Share | 0.10 | -0.17 | 0.09 | -0.03 | -0.53 | -0.27 |
| Gross Margin | 45.77% | 13.01% | 31.27% | 40.00% | -1.65% | 57.37% |
| Operating Margin | 28.89% | -10.43% | 7.33% | 15.97% | -27.32% | -53.36% |
| Profit Margin | 23.50% | -12.52% | 5.49% | 12.69% | -31.33% | -71.92% |
| Free Cash Flow Margin | 9.51% | -25.84% | 13.84% | -3.77% | -53.80% | -30.62% |
| EBITDA | 24.86M | -4.04M | 5.22M | 11.65M | -11.93M | -19.34M |
| EBITDA Margin | 30.84% | -7.65% | 9.78% | 17.79% | -25.04% | -50.44% |
| D&A For EBITDA | 1.57M | 1.47M | 1.30M | 1.19M | 1.09M | 1.12M |
| EBIT | 23.29M | -5.50M | 3.92M | 10.46M | -13.01M | -20.46M |
| EBIT Margin | 28.89% | -10.43% | 7.33% | 15.97% | -27.32% | -53.36% |
| Effective Tax Rate | 19.26% | 29.42% | 2.96% | |||
| Revenue as Reported | 80.62M | 52.74M | 53.40M | 65.49M | 47.64M | 38.35M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 27.42M | 14.68M | 19.76M | 23.63M | 17.11M | 38.98M |
| Short-Term Investments | 13.24M | 15.59M | 15.07M | 20.93M | 5.07M | |
| Cash & Short-Term Investments | 40.66M | 30.27M | 34.83M | 44.56M | 22.18M | 38.98M |
| Accounts Receivable | 16.50M | 8.84M | 2.91M | 5.27M | 4.59M | 3.44M |
| Other Receivables | 634.00K | 486.00K | 482.00K | 364.00K | 311.00K | |
| Receivables | 16.50M | 9.47M | 3.40M | 5.75M | 4.95M | 3.75M |
| Inventory | 32.29M | 25.73M | 21.24M | 19.05M | 16.80M | 17.95M |
| Prepaid Expenses | 394.00K | 500.00K | 444.00K | 774.00K | 905.00K | |
| Other Current Assets | 2.77M | 803.00K | 110.00K | 129.00K | 172.00K | 69.00K |
| Total Current Assets | 92.22M | 66.67M | 60.08M | 69.93M | 44.88M | 61.67M |
| Property, Plant & Equipment | 13.64M | 12.58M | 10.02M | 10.88M | 9.64M | 9.92M |
| Long-Term Deferred Tax Assets | 2.37M | 2.52M | 2.86M | 3.09M | ||
| Other Long-Term Assets | 2.10M | 578.00K | 462.00K | 528.00K | 1.27M | 2.08M |
| Total Assets | 110.34M | 82.35M | 73.42M | 84.43M | 55.79M | 73.67M |
| Accounts Payable | 6.51M | 5.26M | 4.53M | 4.32M | 5.86M | 6.99M |
| Accrued Expenses | 16.38M | 14.53M | 13.80M | 13.20M | 11.60M | 16.34M |
| Current Portion of Long-Term Debt | 20.25M | |||||
| Current Portion of Leases | 1.67M | 1.38M | 1.50M | 1.41M | 1.12M | 1.21M |
| Current Income Taxes Payable | 4.21M | 2.95M | 3.48M | 2.88M | 530.00K | |
| Current Unearned Revenue | 13.18M | 8.55M | ||||
| Other Current Liabilities | 2.62M | 2.40M | 2.31M | 3.48M | 143.00K | 95.00K |
| Total Current Liabilities | 31.39M | 26.52M | 25.62M | 45.53M | 32.43M | 33.18M |
| Long-Term Debt | 28.19M | 27.89M | ||||
| Long-Term Leases | 7.54M | 6.94M | 4.03M | 4.62M | 4.17M | 4.38M |
| Long-Term Unearned Revenue | 11.79M | |||||
| Pension & Post-Retirement Benefits | 661.00K | 559.00K | 714.00K | 1.64M | 2.47M | |
| Total Liabilities | 38.93M | 34.12M | 30.21M | 50.87M | 66.43M | 79.70M |
| Common Stock | 81.00K | 80.00K | 76.00K | 73.00K | 54.00K | 46.00K |
| Additional Paid-In Capital | 434.23M | 433.15M | 421.53M | 415.05M | 379.17M | 368.85M |
| Retained Earnings | -362.90M | -385.00M | -378.39M | -381.55M | -389.86M | -374.93M |
| Shareholders' Equity | 71.40M | 48.23M | 43.21M | 33.57M | -10.64M | -6.04M |
| Total Liabilities & Equity | 110.34M | 82.35M | 73.42M | 84.43M | 55.79M | 73.67M |
| Total Debt | 9.21M | 8.32M | 5.53M | 26.28M | 33.47M | 33.47M |
| Net Cash (Debt) | 31.45M | 21.95M | 29.30M | 18.28M | -11.29M | 5.51M |
| Net Cash Per Share | 0.39 | 0.28 | 0.36 | 0.22 | -0.23 | 0.12 |
| Filing Date Shares Outstanding | 80.57M | 80.57M | 78.03M | 73.05M | 57.35M | 46.32M |
| Total Common Shares Outstanding | 80.57M | 80.43M | 75.85M | 72.95M | 53.79M | 45.56M |
| Working Capital | 60.83M | 40.16M | 34.46M | 24.40M | 12.45M | 28.49M |
| Book Value Per Share | 0.89 | 0.60 | 0.57 | 0.46 | -0.20 | -0.13 |
| Tangible Book Value | 71.40M | 48.23M | 43.21M | 33.57M | -10.64M | -6.04M |
| Tangible Book Value Per Share | 0.89 | 0.60 | 0.57 | 0.46 | -0.20 | -0.13 |
| Machinery | 23.86M | 22.42M | 22.02M | 21.32M | 20.95M | |
| Leasehold Improvements | 18.07M | 17.91M | 17.64M | 16.92M | 16.76M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 18.95M | -6.60M | 2.93M | 8.31M | -14.93M | -27.58M |
| Depreciation & Amortization | 1.57M | 1.47M | 1.30M | 1.19M | 1.09M | 1.12M |
| Other Amortization | 267.00K | 300.00K | 2.67M | |||
| Loss (Gain) From Sale of Assets | -3.00K | 9.00K | -51.00K | |||
| Stock-Based Compensation | 2.26M | 2.30M | 3.25M | 3.45M | 2.08M | 2.38M |
| Other Operating Activities | 1.53M | 948.00K | 377.00K | -4.01M | -1.53M | 1.28M |
| Change in Accounts Receivable | -7.60M | -5.89M | 2.32M | -428.00K | -1.19M | -1.03M |
| Change in Inventory | -11.16M | -4.49M | -2.20M | -2.24M | 1.15M | -4.87M |
| Change in Accounts Payable | 6.36M | 292.00K | 696.00K | 5.29M | -4.80M | 2.38M |
| Change in Unearned Revenue | -13.18M | -7.16M | 13.23M | |||
| Change in Other Net Operating Assets | -1.98M | -15.00K | -4.00K | 13.00K | -5.00K | 190.00K |
| Operating Cash Flow | 9.92M | -11.99M | 8.67M | -1.32M | -25.00M | -10.29M |
| Capital Expenditures | -2.25M | -1.64M | -1.28M | -1.15M | -628.00K | -1.46M |
| Sale of Property, Plant & Equipment | 3.00K | 53.00K | ||||
| Investment in Securities | 2.00M | 5.42M | -15.42M | -5.00M | 20.00M | |
| Other Investing Activities | -773.00K | -728.00K | 80.00K | -142.00K | 593.00K | 327.00K |
| Investing Cash Flow | -1.03M | -2.37M | 4.22M | -16.71M | -5.04M | 18.92M |
| Short-Term Debt Repaid | -4.09M | |||||
| Long-Term Debt Repaid | -20.42M | -30.04M | ||||
| Total Debt Repaid | -20.42M | -34.12M | ||||
| Net Debt Issued (Repaid) | -20.42M | -34.12M | ||||
| Issuance of Common Stock | 296.00K | 9.33M | 3.63M | 24.67M | 8.24M | 46.20M |
| Financing Cash Flow | 296.00K | 9.33M | -16.79M | 24.67M | 8.24M | 12.08M |
| Foreign Exchange Rate Adjustments | 334.00K | -47.00K | 25.00K | -114.00K | -77.00K | 6.00K |
| Net Cash Flow | 9.53M | -5.08M | -3.87M | 6.52M | -21.87M | 20.72M |
| Free Cash Flow | 7.67M | -13.63M | 7.39M | -2.47M | -25.63M | -11.74M |
| Free Cash Flow Margin | 9.51% | -25.84% | 13.84% | -3.77% | -53.80% | -30.62% |
| Free Cash Flow Per Share | 0.10 | -0.17 | 0.09 | -0.03 | -0.53 | -0.27 |
| Levered Free Cash Flow | 2.99M | -12.20M | 5.43M | -1.81M | -7.55M | -12.86M |
| Unlevered Free Cash Flow | 3.76M | -11.45M | 6.10M | -85.50K | -6.27M | -10.83M |
| Cash Interest Paid | 1.53M | 2.74M | 2.20M | 3.41M | ||
| Cash Income Tax Paid | 3.68M | 1.18M | 385.00K | |||
| Change in Working Capital | -14.38M | -10.10M | 811.00K | -10.54M | -12.02M | 9.90M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 208.68M | 144.76M | 138.43M | 129.85M | 69.41M | 37.89M |
| Enterprise Value | 177.23M | 123.57M | 116.71M | 114.89M | 81.74M | 25.96M |
| Last Close Price | 2.59 | 1.80 | 1.88 | 1.78 | 1.37 | 0.83 |
| PE Ratio | 10.95 | 47.21 | 15.62 | |||
| Forward PE | 10.29 | 3.94 | 13.17 | 60.89 | 111.67 | |
| PS Ratio | 2.57 | 2.75 | 2.59 | 1.98 | 1.46 | 0.99 |
| PB Ratio | 2.92 | 3.00 | 3.20 | 3.87 | -6.52 | -6.28 |
| P/TBV Ratio | 2.91 | 3.00 | 3.20 | 3.87 | ||
| P/FCF Ratio | 27.06 | 18.73 | ||||
| P/OCF Ratio | 20.91 | 15.96 | ||||
| EV/Sales Ratio | 2.18 | 2.34 | 2.19 | 1.75 | 1.72 | 0.68 |
| EV/EBITDA Ratio | 7.08 | 22.35 | 9.86 | |||
| EV/EBIT Ratio | 7.56 | 29.80 | 10.98 | |||
| EV/FCF Ratio | 22.96 | 15.79 | ||||
| Debt / Equity Ratio | 0.13 | 0.17 | 0.13 | 0.78 | -3.15 | -5.54 |
| Debt / EBITDA Ratio | 0.34 | 0.81 | 2.00 | |||
| Debt / FCF Ratio | 1.20 | 0.75 | ||||
| Net Debt / Equity Ratio | -0.44 | -0.46 | -0.68 | -0.55 | -1.06 | 0.91 |
| Net Debt / EBITDA Ratio | -1.26 | 5.44 | -5.61 | -1.57 | -0.95 | 0.28 |
| Net Debt / FCF Ratio | -4.10 | 1.61 | -3.96 | 7.41 | -0.44 | 0.47 |
| Asset Turnover | 0.85 | 0.68 | 0.68 | 0.93 | 0.74 | 0.54 |
| Inventory Turnover | 1.64 | 1.95 | 1.82 | 2.19 | 2.79 | 1.05 |
| Quick Ratio | 1.82 | 1.50 | 1.49 | 1.10 | 0.84 | 1.29 |
| Current Ratio | 2.94 | 2.51 | 2.35 | 1.54 | 1.38 | 1.86 |
| Return on Equity (ROE) | 31.24% | -14.44% | 7.64% | 72.50% | ||
| Return on Assets (ROA) | 15.42% | -4.41% | 3.10% | 9.32% | -12.57% | -18.06% |
| Return on Invested Capital (ROIC) | 58.24% | -27.37% | 18.94% | 52.52% | -40.77% | -186.45% |
| Return on Capital Employed (ROCE) | 29.50% | -9.90% | 8.20% | 26.90% | -55.70% | -50.50% |
| Earnings Yield | 9.13% | -4.56% | 2.12% | 6.40% | -21.50% | -72.80% |
| FCF Yield | 3.70% | -9.42% | 5.34% | -1.90% | -36.92% | -31.00% |
| Buyback Yield / Dilution | 2.61% | 3.10% | 1.66% | -70.04% | -9.81% | -51.43% |